Corporate Finance

A silent demographic cliff threatens trillions in assets. With 75% of advisors unprepared for transition, a new framework argues for legacy over exit.

Rokid's $4M Makuake success isn't just a record; it's a signal. With AI translation as the killer app, are smart glasses finally moving from niche to necessary?

The Stoneport Commodity ETF is liquidating after just seven months. Its story reveals the harsh, unsentimental system governing the competitive ETF market.

A small biotech is about to reveal data on a novel drug that could change autoimmune care. Will its bold scientific strategy pay off for patients and investors?

As Pacira BioSciences fends off an activist investor, a high-stakes proxy fight pits long-term R&D against demands for short-term returns.

As AI and crypto converge, a new project bets its future not on speculation, but on tangible utility and verifiable security. We deconstruct the model.

A small biotech just unveiled data for an oral weight-loss pill that appears twice as effective as a key competitor in early tests, shaking up the market.

After its ratings were affirmed, Jordan's MEICO chose to exit AM Best's process. Is this a savvy move to cut costs or a gamble with market transparency?

The S&P/TSX Composite's latest rebalance is more than a market footnote. It's a story of rising commodity players and struggling consumer-facing firms.

Beyond the pitch, a massive government investment aims to leverage the FIFA World Cup to overhaul Canada's sport system and unite a nation.

Allen Control Systems' massive funding for its autonomous Bullfrog weapon reveals a new reality: venture capital is now funding the future of warfare.

A new contract for 243 school workers is more than a local labor win. It’s a strategic investment in the human infrastructure that makes learning possible.

AM Best's stable outlook for Korea P&I isn't just a rating change. It's a validation of a tough, calculated strategy to reduce risk and leverage state support.

SurgePays is building a powerful AI to serve 138 million subprime consumers. But as we chase innovation, we must ask: is this the path to equity or a new digital trap?

Set to join the Russell 3000, Starfighters Space and its unique F-104 fleet bring Wall Street's focus to a new class of aerospace infrastructure.

With a fresh $34.5M in capital, Volatus is set to expand manufacturing and advance its defense-grade drone tech. What does this signal for the industry?

As summer plans ramp up, a new wave of AI-powered scams is set to cost consumers billions. We break down the business of fraud and how to stay protected.

Canadian digital pharmacy TelyRx now trades on OTCQX, a strategic move to access U.S. capital and scale its cash-pay model in a booming market.

Swedish tech firm Einride is going public via SPAC, promising to revolutionize logistics. But behind the $1.35B valuation, what are the real numbers and risks?

A landmark deal between XTransfer and Societe Generale signals more than a partnership; it’s a strategic blueprint to fix the broken plumbing of global trade finance.